Provided by Tiger Trade Technology Pte. Ltd.

MICROPORT

6.075
0.000
Volume:- -
Turnover:- -
Market Cap:11.65B
PE:-6.03
High:6.075
Open:6.075
Low:6.075
Close:6.075
52wk High:16.280
52wk Low:5.830
Shares:1.92B
HK Float Shares:1.92B
Volume Ratio:1.65
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.007
ROE:2.91%
ROA:-0.62%
PB:1.51
PE(LYR):-6.03
PS:1.34

Loading ...

MicroPort Scientific SEHK 853 Loss Narrows To US$46.6 Million Challenging Bearish Narratives

Simply Wall St.
·
Apr 02

Stock Track | MICROPORT Plummets 5.27% Intraday on Leadership Transition Uncertainty

Stock Track
·
Apr 01

MicroPort names Yeung Siu Lam company secretary, authorized representative, replacing Yuen Wing Yan Winnie

Reuters
·
Apr 01

MicroPort names Jonathan W Chen rotating CEO, replacing Zhaohua Chang

Reuters
·
Apr 01

MicroPort FY25 profit hits US$ 38M; revenue rises 6% to US$ 1.1B

Reuters
·
Apr 01

BRIEF-Microport Scientific Says Zhaohua Chang Will No Longer Serve As CEO

Reuters
·
Apr 01

MICROPORT Establishes Global Executive Committee

Stock News
·
Apr 01

Microport Scientific Posts FY Profit Attributable US$48.5 Million

Reuters
·
Mar 31

MicroPort establishes Global Executive Committee and outlines CEO succession effective 2026

Bulletin Express
·
Mar 31

Microport Scientific - Zhaohua Chang Will No Longer Serve as CEO

THOMSON REUTERS
·
Mar 31

MICROPORT Reports 2025 Financial Results with $48.5 Million Profit Attributable to Equity Holders

Stock News
·
Mar 31

MICROPORT Appoints Yang Zhaolin as Company Secretary and Authorized Representative

Stock News
·
Mar 31

MicroPort Returns to Profit in 2025 as Surgical Robots and Overseas Sales Power 7.2% Revenue Growth

Bulletin Express
·
Mar 31

MicroPort announces company secretary transition: Ms. Yuen steps down, Ms. Yeung takes post on 31 Mar 2026

Bulletin Express
·
Mar 31

Microport Scientific - FY Profit Attributable US$48.5 Mln

THOMSON REUTERS
·
Mar 31

BRIEF-Microport Scientific FY Net Profit Attributable For Shanghai Microport Endovascular Medtech Rmb563.3 Million

Reuters
·
Mar 30

MicroPort NeuroScientific’s APOLLO Dream stent wins FDA Breakthrough Device designation

Reuters
·
Mar 30

MicroPort: Endovastec 2025 Revenue Advances 12%, Net Profit to Equity Owners Rises 12.19%

Bulletin Express
·
Mar 30

MicroPort affiliate Endovastec posts RMB 563 million net profit attributable to owners in 2025

Reuters
·
Mar 30

Microport Scientific - FY Revenue for Shanghai Microport Endovascular Medtech RMB1.35 Bln

THOMSON REUTERS
·
Mar 30